Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Today’s News
View:
Post by 13X2413 on Nov 12, 2024 7:45am

Today’s News

Certainly nothing close to what we hoped for. It's clear they're stretching their timelines well into 25. 

This jumps out, the question is, then what???????

  • As of September 30, 2024, the Company reported $19.6 million in cash and cash equivalents. The Company has a projected cash runway through key milestones and into 2025.
Comment by Quantum41 on Nov 12, 2024 9:25am
3 points jumped out for me today; 1. Accelerated approval timing (Kirk) enrollment over 18 month, plus 6 month study. That means 24 month until decision for accel. approval? So we are talking middle of 2027 2. That's also mentioned by Christoph D. About market size, again 2027 mentioned for approval, with a revenue potential of 4 BN by 2030. 3. Cash is 19.6 Mio (Kirk) but total expenditure (my ...more  
Comment by Quentin30 on Nov 12, 2024 11:29am
If cash burn is 9 million a quarter, that leaves 14 1/4 million now...  which means sometme Q2 the lights go out... oh dear.
Comment by spesestsemper on Nov 12, 2024 11:36am
Disappointing call today . They can't seem to get anyone interested in the company .No sense of them wanting to get anything done . Christophe is a big let down .  Holding for now but maybe not much longer . Have to decide if i want to keep dead money for a bit .
Comment by Buckhenry on Nov 12, 2024 12:18pm
Crickets from the pumpers this morning. I agree... but they are running out of capital so will have to do something to raise funds in the near future. Deluting may occur as a result of raising capital. 
Comment by Buckhenry on Nov 12, 2024 12:38pm
Here we go with more worthless mumbo jumbo from ole unnoteable. 
Comment by 13X2413 on Nov 12, 2024 12:42pm
In a way, I'm not shocked that Azz, Not, CF have not chimed in on the latest BS news. Even they must be concerned.  Noteless doesn't even bother to comment, instead goes right to the mumbo jumbo about other companies.  Strange, but not surprising    
Comment by spesestsemper on Nov 12, 2024 12:53pm
He probably does that to push other posts he doesn't agree with down in the thread . Lets be honest - the only thing that will get the share price going is a partner deal . You can have the greatest thing since slice bread but if no one is willing to put up the money , it doesn't really matter . It really concerned me when christophe mentioned looking to asia , does that mean others aren ...more  
Comment by Azzak34 on Nov 12, 2024 1:53pm
Aww numbers, you feeling the pressure? Great news on the call, Pela keeps showing what it can do. You and the and the rest of the Backstreet Boys keep sowing that FUD but I'm more than happy. Dollar Cost Averaging at this point and it feels just lovely.  Can't take the heat, get outta the kitchen ladies. 
Comment by Investor5876 on Nov 12, 2024 2:08pm
Tea leaves... ONC has almost completely stopped using the ATM.  They total shares issued grew by only 1.6 million shares between March 31st and September 31st.  This is a trivial amount for ONC considering they are bleeding cash and they appear to be on a quick trip to bankruptcy. They are on pace to run out of cash mid 2025. And yet they leave the ATM untapped.  This can only ...more  
Comment by canadafan on Nov 12, 2024 3:26pm
Intersting C.C & equally interesting responses on here. ill start & end my thoughts, on the CC First, & not discussed. Dr. Matt is still off sick. Regarding the CC content. There were some very specific questions from 3 separate analysts. Will be interesting to see their responses going forward. upgrade,downgrade or stay the same? My guess is staying the same. or improved ...more  
Comment by Jf4270393 on Nov 12, 2024 3:47pm
Excellent post Canadafan. Your experience and maturity always shine through. in your postings.
Comment by Buckhenry on Nov 12, 2024 4:24pm
As I stated earlier they will have to get some form of capital soon. All the BS mumbo jumbo emotional posting does not aid in the BOD making a decision. Sorry forever pumpers. 
Comment by Azzak34 on Nov 12, 2024 5:04pm
Your powers of reason and deduction are 2nd to none Buckster. What algorithm do you use to work out that a biotech needs cash before their product hits the market?  Can I interest you in a hobby? Maybe a friend? So that you can spend some time not on here being a silly Billy.  That share price going up today must have been a dagger in to that lonely heart of yours. 
Comment by Buckhenry on Nov 12, 2024 9:31pm
Unnoteable... I'm sure based on your 6 reasons some company will surely take notice and a buyout will be imminent... they will probably want you on the board...
Comment by 13X2413 on Nov 13, 2024 10:26am
Another update from the company, another sell off from investors. They're not fooling anybody anymore. Available cash into early 2025 is not enough when they're throwing out results dates well beyond that.  
Comment by venture009 on Nov 13, 2024 10:45am
It would seem securing a partner/buyout is becoming nothing more than a dream.  BP know the ins and outs of this company and one would have expected some kind of offer by now if pela was as advantages as some are suggesting. BP is greedy so one of them would have made a move. One thing is clear they are going to run out of money. 
Comment by CMHarring218431 on Nov 13, 2024 11:09am
Venture, Perhaps, that is exactly the point. Things are progressing with Oncy doing the work for now. When the cash crunch is imminent, one of the BP's steps in as the white knight when Oncy is desperate. Stock price may not matter but cash certainly does. Negotiate ? What is going to be their leverage? Call Elon?
Comment by venture009 on Nov 13, 2024 11:27am
Checkout CLDI, a potential competitor in the OV market. Getting huge traction on their glio therapy. To me they are years behind but rumor has it they are having great results with their trial.
Comment by CMHarring218431 on Nov 13, 2024 11:58am
Certainly, a lot of volume for a company with less than 12 mil shares outstanding. Point being. They are a known entity. So many alternative therapies. Are they competiton for Oncy indirectly? Science wise, I have no idea but so many call themselves immuno oncology companies. The shorts can't be entirely responsible. I think lack of promotion is a big one. Remember the ad at a hockey game. are ...more  
Comment by m00nsh0ts on Nov 13, 2024 12:09pm
CLDI was advertising on FOXBusiness over the last couple of months.
Comment by Buckhenry on Nov 13, 2024 1:14pm
Pumpers working hard this morning trying to keep their base energized. Keep up the regurgitated mumbo jumbo. 
Comment by Buckhenry on Nov 13, 2024 2:08pm
Reverse split and delisting letter coming soon. 
Comment by inthno on Nov 12, 2024 7:14pm
Hello and not a bad cc all in all although not really that much new and as for the 2.5 billion in sales for mbc if anyone had bothered to read the october investor presentation on the onc website it is easy to see that it has been there for a month cf so really not new. As for what is new is that This is from the 2nd quarter cc 1)We entered into a collaboration with GCAR for inclusion of pela in ...more  
Comment by Noteable on Nov 12, 2024 8:51pm
These following 6 cancer indications involving pelareorep as a monotherapy or in combination with other cancer agents should be affecting something "critical" for ONCY in the next couple of months, now that the final results for Bracelet-1 have been finally announced and recently shared with Big Pharma, who awaited its release. (1) HR+/HER2 negative metastatic breast cancer; (2 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities